IDG Capital
VC Fund
Beijing, China
IDG Capital is an investment firm that funds early- to growth-stage companies in the technology sector. Today they work with private equity and venture capital fund managers, investment advisors, and business entities from around the world. Their limited partners include many internationally reputable investors, including sovereign wealth funds,pension funds, institutional investors, major charities, university endowments, family offices, and business luminaries.IDG Capital brings a powerful combination of global perspective and local experience to investment management. As long-term value investors, they are highly skilled at mobilizing global resources to address local needs, especially for Inbound and outbound opportunities in China and the rest of Asia. Their highly skilled team has an in-depth understanding of the Chinese market and enjoys close relationships with many influential business leaders.
- Total investments:
- 1129
- Last investment:
- Lead investor:
- 37%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries IDG Capital invests in
Stages IDG Capital invests in
Countries IDG Capital invests in
Round sizes
Contacts
Round size
- Series A
- $2.6M–$100M
- Series B
- $7M–$112M
- Series C
- $15M–$354M
Investment Focus
Industry
- Software 62 (5%)
- Internet 54 (5%)
- E-Commerce 53 (5%)
- Artificial Intelligence 46 (4%)
- Health Care 42 (4%)
Stage
- Series A 205 (18%)
- Series B 173 (15%)
- Series C 75 (7%)
- Seed 68 (6%)
- Angel 36 (3%)
Country
- China 381 (34%)
- United States 44 (4%)
- India 9 (1%)
- Singapore 6 (1%)
- South Korea 6 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Hui Shao
Entrepreneur-In-Residence
|
Entrepreneur-In-Residence | Total investments: 1 | Find email | |
|
Meng Lian
VP
|
VP | Total investments: 1 | Find email | |
|
Xinhua Yu
Team Member
|
Team Member | Total investments: 12 | Find email | |
|
Young Guo
General Partner
|
General Partner | Total investments: 4 | Find email | |
|
Bin Yue
Team Member
|
Team Member | Total investments: 6 | Find email | |
| See all 23 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Vibronix was founded by Dr. Ji-Xin Cheng and Dr. Pu Wang at Purdue University. We aim to provide advanced imaging and sensor technologies for disease diagnosis and treatment. We specifically focus on the development of optical & acoustic technologies for surgical guidiance. | $14.9M / Series B / Sep 14, 2026 | |
|
|
Feimo Technology is a developer of embody intelligent technology, mainly engaged in the research and development of industrial robots, sales of intelligent robots, and manufacturing of special-purpose robots. | Seed / Sep 09, 2026 | |
|
Infinite Workshop
|
Infinite Workshop is focuses on desktop CNC machining and then-popular embody robots. | Venture - Series Unknown / Aug 28, 2026 | |
|
|
Xpeng Robotics a Shenzen, China-based affiliate of XPeng Inc. and a key part of its mobility ecosystem dedicated to creating smart robots, | $900M / Series A / Aug 24, 2026 | |
|
|
SiranBio is a biotechnology that develops innovative siRNA drugs. | $59.5M / Series A / Aug 20, 2026 | |
|
Shumeiwuwu
|
Shumeiwuwu is a cross-border e-commerce company that provides quality goods and services to consumers through global shopping. | Series A / Aug 20, 2026 | |
|
Vector Singularity
|
Vector Singularity is a cutting-edge technological business that researches and develops neutral atom quantum computers. | $14.8M / Angel / Aug 14, 2026 | |
|
|
Hongxin Bio is an mRNA drug developer, focusing on nucleic acid drug delivery and RNA drug development. | Series B / Aug 13, 2026 | |
|
|
Qiuzhi Technology focused on merging artificial intelligence and robotics, with an objective of bringing robots into households. | $100M / Angel / Aug 03, 2026 | |
|
|
Ractigen is an early-stage pharmaceutical company committed to bringing to market first-in-class therapies designed to selectively restore the expression of therapeutic genes silenced in diseased cells. Its core technology is based on a paradigm-shifting discovery made at the University of California San Francisco (UCSF) known as RNA activation(RNAa). Founded in 2016 by the pioneers in the field, Ractigen is developing a rich pipeline of candidate medicines for patients with unmet need. | $31M / Venture - Series Unknown / Jul 29, 2026 | |
| See all 1129 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does IDG Capital invest in?
IDG Capital invests primarily in Software, Internet and E-Commerce startups, most often at Series A and Series B stage. Most of the 1,129 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is IDG Capital's check size?
IDG Capital typically joins rounds of $2.6M–$100M at Series A, $7M–$112M at Series B and $15M–$354M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds IDG Capital participates in.
How do I contact IDG Capital?
Public channels for IDG Capital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at IDG Capital?
The team at IDG Capital includes Hui Shao (Entrepreneur-In-Residence), Meng Lian (VP) and Xinhua Yu (Team Member), among 23 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!